VWWMG
NVAX icon

Vermillion & White Wealth Management Group’s Novavax NVAX Stock Holding History

Vermillion & White Wealth Management Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23
Closed -$154 – 370
2025
Q4 		$154 Buy
+23
New +$173 ﹤0.01% 567

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vermillion & White Wealth Management Group's NVAX Position: Q1 2026 in Review

Vermillion & White Wealth Management Group sold out of Novavax (NVAX) in Q1 2026, closing a stake of 23 shares — an estimated $154 sold.

Vermillion & White Wealth Management Group first reported a position in NVAX in Q4 2025 and held it in 1 quarter. The position peaked at $154 in Q4 2025. 259 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Vermillion & White Wealth Management Group reported no remaining Novavax position as of Q1 2026 after selling out during the quarter.
  • Vermillion & White Wealth Management Group sold 23 Novavax shares in Q1 2026, an estimated $154.
  • Vermillion & White Wealth Management Group first reported a position in Novavax in Q4 2025 and held it in 1 quarter.
  • Vermillion & White Wealth Management Group's Novavax position peaked at $154 in Q4 2025.
  • 259 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Vermillion & White Wealth Management Group's 13F filing for Q1 2026, filed 14 May 2026.